Verbatim response from ChatGPT
Short answer: No — compounded “GLP‑1 drops” or home‑made tablets are unreliable and not recommended. If you want an oral GLP‑1, use the FDA‑approved product (Rybelsus/semaglutide). For stronger, better‑studied effects, use the approved injectables (Ozempic/Wegovy — semaglutide; Mounjaro/Zepbound — tirzepatide; Victoza/Saxenda — liraglutide) under medical supervision.
Why compounded oral GLP‑1s are a problem
- Peptides are fragile: most GLP‑1 drugs are peptides that are destroyed in the stomach/GI tract. Rybelsus works only because it has a special absorption enhancer (SNAC) and has been tested in trials. Compounded formulations usually do not replicate that technology.
- No regulatory oversight: compounded products are not FDA‑approved, so their potency, purity, stability and sterility can be highly variable. Independent testing of some compounded GLP‑1 products has shown inconsistent or missing active drug.
- Safety and legal concerns: quality control, contamination or wrong dosing are real risks. You also lose the safety data that accompanies approved products.
- Efficacy: there’s no reliable clinical evidence that compounded drops/tablets provide the same blood levels or clinical benefits as approved drugs.
How approved options compare
- Rybelsus (oral semaglutide): the only widely approved oral GLP‑1. It’s less bioavailable than injectable semaglutide and is taken daily with specific fasting/water instructions. Effective for glucose control; weight‑loss effect is generally smaller than weekly injectables at current doses.
- Injectables (weekly or daily): Ozempic (semaglutide), Wegovy (semaglutide for weight), Mounjaro and Zepbound (tirzepatide) produce larger and more consistent weight‑loss and glucose‑lowering effects in trials. Tirzepatide currently shows among the largest weight‑loss results.
- Safety: all can cause nausea, vomiting, possible gallbladder issues, pancreatitis risk, and have other contraindications (e.g., personal/family history of certain thyroid tumors). Use only with clinician oversight.
What I recommend
- Avoid compounded GLP‑1 drops/tablets — they’re unproven and potentially unsafe.
- If you want an oral option, talk to your clinician about Rybelsus (semaglutide oral).
- If you need stronger results, discuss injectable options (Wegovy/Ozempic for semaglutide; Mounjaro/Zepbound for tirzepatide).
- If cost or access is the issue, ask your provider or pharmacist about manufacturer savings programs, coupons, patient assistance, or alternatives your insurer covers.
- Don’t buy “GLP‑1 drops” from online vendors that bypass prescriptions; use a licensed prescriber and reputable pharmacy.
If you’d like, tell me whether your main goal is diabetes control or weight loss, any medical history (pregnancy, pancreatitis, thyroid cancer, kidney disease), and whether cost/route (oral vs injection) is a deciding factor — I can help you compare specific drugs and options for your situation.